Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 1,498 shares at $23.10 ($35K) on 2017-01-18, disclosed to the SEC on 2017-01-20.
Open-market sale of $35k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2016-10-19 | $165K | — | Filing → |
| ALDR | SELL | 2016-06-15 | $171K | — | Filing → |
| ALDR | SELL | 2016-06-01 | $751K | — | Filing → |